TAKING STOCK
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.rShares in Scholl, the healthcare products group under siege from rebel shareholders led by Julian Tregar, hardened a penny to 230p after announcing approaches had been received from several interested parties. Talks are at an early stage, and the company stressed that there was no certainty of a bid being made. One of the approaches is from a private French pharmaceutical business.
rFinding a vacant room at top London hotels is proving difficult these days, but finding buyers for hotels is proving to be easier. Following the sale of the Ritz to the Barclay twins, it now transpires that someone wants to check into the smaller and less glamorous Park Lane Hotel. The shares, one of the first draft on the new Ofex market, are trading at around pounds 7, implying a value for the hotel of pounds 30m.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments